Postoperative low dose rate (LDR) brachytherapy alone for T1-2 N0-1 squamous cell carcinoma (SCCa) of the oral tongue

被引：0
|
作者：
Biagioli, M. [1 ]
Hu, K. [1 ]
Thawani, N. [1 ]
Harrison, L. B. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Continuum Canc Ctr New York, New York, NY 10003 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2008.06.1291
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S403 / S404
页数：2
相关论文
共 50 条
  • [1] Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive margins
    Lapeyre, M
    Hoffstetter, S
    Peiffert, D
    Guérif, S
    Maire, F
    Dolivet, G
    Toussaint, B
    Mundt, A
    Chassagne, JF
    Simon, C
    Bey, P
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (01): : 37 - 42
  • [2] Results of sole postoperative interstitial, high-dose-rate brachytherapy of T1-2 tongue tumours
    Takacsi-Nagy, Zoltan
    Ferenczi, Ors
    Major, Tibor
    Akiyama, Hironori
    Frohlich, Georgina
    Oberna, Ferenc
    Revesz, Monika
    Poosz, Marton
    Polgar, Csaba
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (09) : 812 - 819
  • [3] Clinical outcome of surgical treatment of T1-2 N0 oral tongue squamous cell carcinoma with wait and watch for the neck
    Hakeem, A. -H.
    Pradhan, S. -A.
    Kannan, R.
    [J]. ORAL ONCOLOGY, 2011, 47 : S64 - S64
  • [4] Risks and clinical implications of perineural invasion in T1-2 oral tongue squamous cell carcinoma
    Tai, Shyh-Kuan
    Li, Wing-Yin
    Chu, Pen-Yuan
    Chang, Shyue-Yih
    Tsai, Tung-Lung
    Wang, Yi-Fen
    Huang, Jui-Lin
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (07): : 994 - 1001
  • [5] Role of Surgery in Limited (T1-2, N0-1) Cancers of the Oropharynx
    Walvekar, Rohan R.
    Li, Ryan J.
    Gooding, William E.
    Gibson, Michael K.
    Heron, Dwight
    Johnson, Jonas T.
    Ferris, Robert L.
    [J]. LARYNGOSCOPE, 2008, 118 (12): : 2129 - 2134
  • [6] Exclusive LDR brachytherapy in 279 patients with T2N0 tongue carcinoma
    Bourgier, C
    Coche-Dequeant, B
    Fournier, C
    Castelain, B
    Prevost, B
    Lacornerie, T
    Castellanos, E
    Lartigau, E
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S59 - S59
  • [7] Prognostic factors in limited (T1-2, N0-1) oropharyngeal carcinoma treated with surgery ± adjuvant therapy
    Psychogios, Georgios
    Mantsopoulos, Konstantinos
    Agaimy, Abbas
    Koch, Michael
    Zenk, Johannes
    Waldfahrer, Frank
    Iro, Heinrich
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (12): : 1752 - 1758
  • [8] Clinical Outcomes of Patients With pT1-T2N0 Oral Tongue Squamous Cell Carcinoma
    Wilson, Jessica M.
    Lumley, Catherine
    Tan, Xianming
    Shen, Colette
    Coniglio, Andrew
    Weissler, Mark
    Yarbrough, Wendell G.
    Hackman, Trevor
    Blumberg, Jeffrey
    Zanation, Adam
    Thorp, Brian
    Patel, Samip N.
    Chera, Bhishamjit S.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (05): : 200 - 205
  • [9] Transoral bisected resection for T1-2 oral tongue squamous cell carcinoma to secure adequate deep margin
    Choi, Nayeon
    Cho, Jae-Keun
    Lee, Eun Kyu
    Won, Sung Jun
    Kim, Bo Young
    Baek, Chung-Hwan
    [J]. ORAL ONCOLOGY, 2017, 73 : 70 - 76
  • [10] Exclusive low-dose-rate brachytherapy in 279 patients with T2N0 mobile tongue carcinoma
    Bourgier, C
    Coche-Déquéant, B
    Fournier, C
    Castelain, B
    Prévost, B
    Lefebvre, JL
    Lartigau, E
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : 434 - 440
12345